These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15116814)

  • 1. The potential use of recombinant activated factor VII in trauma and surgery.
    Sapsford W
    Scand J Surg; 2004; 93(1):17-23. PubMed ID: 15116814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma.
    Martinowitz U; Kenet G; Lubetski A; Luboshitz J; Segal E
    Can J Anaesth; 2002 Dec; 49(10):S15-20. PubMed ID: 12546003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of recombinant activated factor VII in the control of haemorrhage following blunt pelvic trauma.
    Udy A; Vaghela M; Lawton G; Sigston P
    Anaesthesia; 2005 Jun; 60(6):613-6. PubMed ID: 15918835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant activated factor VII: its mechanism of action and role in the control of hemorrhage.
    Allen GA; Hoffman M; Roberts HR; Monroe DM
    Can J Anaesth; 2002 Dec; 49(10):S7-14. PubMed ID: 12546000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel hemostatic agent: the potential role of recombinant activated factor VII (rFVIIa) in anesthetic practice.
    Murkin JM
    Can J Anaesth; 2002 Dec; 49(10):S21-6. PubMed ID: 12546007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
    Brenner B; Wiis J
    Hematology; 2007 Feb; 12(1):55-62. PubMed ID: 17364994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential role of recombinant factor VIIa as a hemostatic agent.
    Hedner U; Erhardtsen E
    Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emerging role of recombinant-activated factor VII in neurocritical care.
    Fewel ME; Park P
    Neurocrit Care; 2004; 1(1):19-29. PubMed ID: 16174895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing uncontrolled hemorrhage in trauma and surgery: a novel and promising approach.
    Hardy JF
    Can J Anaesth; 2002 Dec; 49(10):S4-6. PubMed ID: 12545999
    [No Abstract]   [Full Text] [Related]  

  • 10. Recombinant factor VIIa in the treatment of postoperative hemorrhage after cardiac surgery.
    Raivio P; Suojaranta-Ylinen R; Kuitunen AH
    Ann Thorac Surg; 2005 Jul; 80(1):66-71. PubMed ID: 15975342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant factor VIIa in the treatment of bleeding.
    Midathada MV; Mehta P; Waner M; Fink LM
    Am J Clin Pathol; 2004 Jan; 121(1):124-37. PubMed ID: 14750250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting response to recombinant factor VIIa in non-haemophiliac patients with severe haemorrhage.
    Bowles KM; Callaghan CJ; Taylor AL; Harris RJ; Pettigrew GJ; Baglin TP; Park GR
    Br J Anaesth; 2006 Oct; 97(4):476-81. PubMed ID: 16914465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant factor VIIa (rFVIIa) and its use in severe bleeding in surgery and trauma: a review.
    Grounds M
    Blood Rev; 2003 Sep; 17 Suppl 1():S11-21. PubMed ID: 14697209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of recombinant factor VIIA for control of combat-related haemorrhage.
    Woodruff SI; Dougherty AL; Dye JL; Mohrle CR; Galarneau MR
    Emerg Med J; 2010 Feb; 27(2):121-4. PubMed ID: 20156864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task Force.
    Martinowitz U; Michaelson M;
    J Thromb Haemost; 2005 Apr; 3(4):640-8. PubMed ID: 15842347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Off-license" use of recombinant activated factor VII.
    Ghorashian S; Hunt BJ
    Blood Rev; 2004 Dec; 18(4):245-59. PubMed ID: 15501553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective management of refractory postcardiotomy bleeding with the use of recombinant activated factor VII.
    Filsoufi F; Castillo JG; Rahmanian PB; Scurlock C; Fischer G; Adams DH
    Ann Thorac Surg; 2006 Nov; 82(5):1779-83. PubMed ID: 17062247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant activated coagulation factor VII and bleeding trauma patients.
    Rizoli SB; Nascimento B; Osman F; Netto FS; Kiss A; Callum J; Brenneman FD; Tremblay L; Tien HC
    J Trauma; 2006 Dec; 61(6):1419-25. PubMed ID: 17159685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic interventions for the management of critical bleeding.
    Voils S
    Pharmacotherapy; 2007 Sep; 27(9 Pt 2):69S-84S. PubMed ID: 17723110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging off-label uses for recombinant activated factor VII: grading the evidence.
    Enomoto TM; Thorborg P
    Crit Care Clin; 2005 Jul; 21(3):611-32. PubMed ID: 15992675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.